Изменения
Ответ на Ссылки на исследования
Вот исследование на людях - рандомизированное, двойное слепое, плацебо-контролируемое.
http://calzada.com.au/wp-content/uploads/2013/05/Safety-and-Tolerability-of-the-Hexadecapeptide-AOD9604-in-Humans.pdf
tl;dr:
Results: AOD9604 had no effect on serum IGF-1 levels, which confirms the hypothesis that AOD9604 does not act via IGF-1. Results of oral glucose tolerance test demonstrated that, in contrast with hGH, AOD9604 has no negative effect on carbohydrate metabolism. There were no anti-AOD9604 antibodies detected in any of the patients selected for antibody assay. In none of the studies did a withdrawal or serious adverse event occur related to intake of AOD9604.
http://calzada.com.au/wp-content/uploads/2013/05/Safety-and-Tolerability-of-the-Hexadecapeptide-AOD9604-in-Humans.pdf
tl;dr:
Results: AOD9604 had no effect on serum IGF-1 levels, which confirms the hypothesis that AOD9604 does not act via IGF-1. Results of oral glucose tolerance test demonstrated that, in contrast with hGH, AOD9604 has no negative effect on carbohydrate metabolism. There were no anti-AOD9604 antibodies detected in any of the patients selected for antibody assay. In none of the studies did a withdrawal or serious adverse event occur related to intake of AOD9604.